Skip to content

OMTX705-006 Phase 1b

Status
Recruiting
Phases
Phase 1
Study type
Interventional
Source
EU CTIS
Registry ID
CTIS2025-521872-69-00
Acronym
OMTX705-006
Enrollment
54
Registered
2025-09-01
Start date
2025-10-28
Completion date
Unknown
Last updated
2025-10-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Advanced/Metastatic Pancreatic Adenocarcinoma

Interventions

None listed

Sponsors

Oncomatryx Biopharma S.L.
Lead SponsorINDUSTRY

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Countries

Spain

Outcome results

None listed

Source: EU CTIS · Data processed: Feb 4, 2026